The drug maker on Tuesday announced that it has received a final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Glycopyrrolate Injection USP.
Airwallex partners with University of Melbourne to forge Australia’s future tech leaders
The latest PMI results indicated that economic growth in the Indian manufacturing industry remained robust, and price pressures were contained. October data showed historically marked expansions in factory orders and quantities of purchases, while production growth outpaced its long-run average despite softening to a four-month low. At the same time, cost burdens rose at a broadly similar rate to Septembers 23-month low, while selling charge […]
The key equity barometers continued to trade with strong gains in mid-morning trade. The Nifty, however, traded below the 18,150 level. Auto shares extended gains for sixth consecutive session. At 11:29 IST, the barometer index, the S&P BSE Sensex, was up 423.89 points or 0.70% to 61,170.48. The Nifty 50 index gained 129.60 points or 0.72% to 18,141.80. In the broader market, the S&P BSE […]
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
